Company profile
Regenerative Medical Technology Group Inc.
OTC: RMTG · Healthcare · Biotechnology
#705 of 1,418 Healthcare companies by revenue69th-percentile growth
EA Score
36DFH 31DQ 34GM 56SS 39
v0.1 · 65/100 weight · provisional
↑ listing tenure, 3-yr revenue growth · ↓ workforce scale, balance-sheet leverage
Methodology →Revenue TTM
$9.4M
Rev growth YoY (TTM)
+94.3%
Net income (FY)
-$7.8M
Employees
1
as of 2026-08-27
Market cap
$985.4k
as of 2026-08-27
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$5.1M$5.1M2025
Net income-$7.8M-$7.8M2025
Operating income-$867.2k-$867.2k2025
Total assets$4.5M$4.5M2025
Liabilities$39.2M$39.2M2025
Equity-$34.7M-$34.7M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Regenerative Medical Technology Group Inc.’s revenue?
Regenerative Medical Technology Group Inc. booked $5.1M in FY2025 revenue, growing 24% year over year — faster than most Healthcare companies we track, at a -153.2% net margin.
Peers · Healthcare
Zeo ScientifiX, Inc.43DRadiko Holdings Corp——Petros Pharmaceuticals, Inc.48DWellbeing Digital Sciences Inc.——Ensysce Biosciences, Inc.31DBanyan Corp.——Neighbors
Palm Beach →Key facts
CEODavid Christensen
SectorHealthcare
IndustryBiotechnology
HeadquartersBoca Raton, FL
ExchangeOTC: RMTG
Employees1
IPO date1999-09-13
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.